AKT1 and esophageal squamous cell carcinoma: The protein level of p-Akt in ESCC cells decreased upon treatment with the UA and PTX combination, and that decrease was significantly suppressed by the Akt inhibitor LY294002 and induced by the Akt activator SC79.